Literature DB >> 10192714

Comparative activity of eighteen antimicrobial agents against anaerobic bacteria isolated in South Africa.

M M Lubbe1, P L Botha, L J Chalkley.   

Abstract

The in vitro activity of 18 antimicrobial agents was determined against 378 anaerobic bacteria isolated in Bloemfontein, South Africa, during 1996/97. Against the gram-positive isolates, MICs of penicillin and cefoxitin were >0.5 microg/ml and >16 microg/ml, respectively, for five and three strains of non-perfringens Clostridium spp. Seventeen Peptostreptococcus anaerobius strains were resistant to penicillin (MIC > or = 2 microg/ml). All gram-positive anaerobes tested except one Peptostreptococcus sp. and one Clostridium sp. were susceptible to dalfopristin-quinupristin (MICs < or = 1 microg/ml). The carbapenems exhibited excellent activity against the gram-positive isolates and were effective against most gram-negative anaerobes, with the exception of the fusobacteria. Only seven strains exhibited decreased susceptibility to trovafloxacin (MICs > 2 microg/ml). In mixed anaerobic/aerobic infections, carbapenems and the fourth-generation quinolone trovafloxacin were the agents most suitable for us as broad-spectrum monotherapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192714     DOI: 10.1007/s100960050225

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

Review 1.  Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.

Authors:  H M Lamb; D P Figgitt; D Faulds
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Elucidation of the Molecular Mechanisms of Action of the Natural Antimicrobial Peptide Subtilosin Against the Bacterial Vaginosis-associated Pathogen Gardnerella vaginalis.

Authors:  Katia Sutyak Noll; Patrick J Sinko; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-03       Impact factor: 4.609

3.  Bacteremia caused by a metronidazole-resistant Prevotella sp. strain.

Authors:  Francine Mory; Jean-Philippe Carlier; Corentine Alauzet; Maxime Thouvenin; Hélène Schuhmacher; Alain Lozniewski
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.

Authors:  K E Aldridge; D Ashcraft; K Cambre; C L Pierson; S G Jenkins; J E Rosenblatt
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

5.  Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources.

Authors:  Eija Könönen; Anne Bryk; Päivi Niemi; Arja Kanervo-Nordström
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

Review 6.  The aetiology of bacterial vaginosis.

Authors:  Y Turovskiy; K Sutyak Noll; M L Chikindas
Journal:  J Appl Microbiol       Date:  2011-03-14       Impact factor: 3.772

7.  The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and ε-poly-L-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli.

Authors:  Katia Sutyak Noll; Mark N Prichard; Arkady Khaykin; Patrick J Sinko; Michael L Chikindas
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

8.  Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates.

Authors:  David W Hecht; J R Osmolski
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

9.  In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.

Authors:  A Liebetrau; A C Rodloff; J Behra-Miellet; L Dubreuil
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

10.  Spermicidal activity of the safe natural antimicrobial peptide subtilosin.

Authors:  Katia E Sutyak; Robert A Anderson; Sara E Dover; Kenneth A Feathergill; Alla A Aroutcheva; Sebastian Faro; Michael L Chikindas
Journal:  Infect Dis Obstet Gynecol       Date:  2008-10-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.